Biocept, Inc. (Nasdaq: BIOC) announced the launch of its FGFR1 amplification testing utilizing a patient's blood sample. This diagnostic assay ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE